HQY FY 2019 Earnings Report — HealthEquity, Inc. Revenue & Financial Results | Market Cap Arena

HealthEquity, Inc.HQY

FY 2019 Earnings

Reported March 28, 2019

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2019	Prior Q	FY 2018	QoQ Change	YoY Change
Revenue	$287M	—	$230M	—	25.1%
Op. Income	$78M	—	$54M	—	42.7%
Gross Margin	61.0%	—	56.7%	—	4.4pp
Net Margin	25.7%	—	20.6%	—	5.1pp
EPS (Diluted)	$1.17	—	$0.77	—	51.9%
Free Cash Flow	$98M	—	$48M	—	103.6%

Revenue Flow

Item	Amount
REVENUE	$287M
Cost of Revenue	$112M
GROSS PROFIT	$175M
R&D Expenses	$35M
Selling & Marketing	$29M
General & Administrative	$33M
SG&A Expenses	$63M
Other Expenses	$0
Operating Expenses	$98M
Cost & Expenses	$210M
OPERATING INCOME	$78M
Interest Income	$2M
Interest Expense	$0
Other Income/Expenses	-$2M
INCOME BEFORE TAX	$76M
Income Tax Expense	$2M
Net Income from Continuing Ops	$74M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$74M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$74M
D&A	$18M
EBIT	$76M
EBITDA	$94M
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$287M
Cost of Revenue	$112M
GROSS PROFIT	$175M
R&D Expenses	$35M
Selling & Marketing	$29M
General & Administrative	$33M
SG&A Expenses	$63M
Other Expenses	$0
Operating Expenses	$98M
Cost & Expenses	$210M
OPERATING INCOME	$78M
Interest Income	$2M
Interest Expense	$0
Other Income/Expenses	-$2M
INCOME BEFORE TAX	$76M
Income Tax Expense	$2M
Net Income from Continuing Ops	$74M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$74M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$74M
D&A	$18M
EBIT	$76M
EBITDA	$94M
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$74M
Depreciation & Amortization	$18M
Stock-Based Compensation	$21M
Deferred Income Tax	$408.0K
Other Non-Cash Items	$1M
Change in Working Capital	-$1M
OPERATING CASH FLOW	$113M
Capital Expenditure	-$15M
Acquisitions (Net)	$11M
Purchases of Investments	-$728.0K
Sales/Maturities of Investments	$41M
Other Investing Activities	-$11M
NET CASH FROM INVESTING	$26M
Net Debt Issuance	$0
Common Stock Repurchased	$0
Common Dividends Paid	$0
Other Financing Activities	$0
NET CASH FROM FINANCING	$23M
FREE CASH FLOW	$98M
Net Change in Cash	$162M

Balance Sheet

Item	Amount
Cash & Equivalents	$361M
Short-Term Investments	$0
Net Receivables	$26M
Inventory	$0
Other Current Assets	$8M
TOTAL CURRENT ASSETS	$395M
PP&E (Net)	$8M
Goodwill	$5M
Intangible Assets	$80M
Long-Term Investments	$0
Tax Assets	$2M
Other Non-Current Assets	$21M
TOTAL NON-CURRENT ASSETS	$115M
TOTAL ASSETS	$510M
Account Payables	$4M
Short-Term Debt	$0
Deferred Revenue	$0
Other Current Liabilities	$17M
TOTAL CURRENT LIABILITIES	$29M
Long-Term Debt	$0
Deferred Revenue NC	$0
Deferred Tax Liabilities	$916.0K
Other Non-Current Liabilities	$3M
TOTAL NON-CURRENT LIABILITIES	$4M
TOTAL LIABILITIES	$33M
Common Stock	$6.0K
Additional Paid-In Capital	$305M
Retained Earnings	$172M
Treasury Stock	$0
Accum. Other Comp. Income	$0
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$477M
Minority Interest	$0
TOTAL EQUITY	$477M
TOTAL LIABILITIES & EQUITY	$510M
Total Debt	$0
Net Debt	-$361M